References
- Farber E, Cameron R. The sequential analysis of cancer development. Adv Cancer Res 1980; 31: 125–226
- Foulds L. Neoplastic Development I and 2. Academic Press, New York 1969, 1975
- Farber E. Carcinogenesis-cellular evolution as a unifying thread-Presidential Address. Cancer Res 1973; 33: 2537–2550
- Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture. Cancer Res 1984; 44: 5463–5474
- Farber E, Sarma D SR. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987; 56: 4–22
- Farber E, Parker S, Gruenstein M. The resistance of putative premalignant liver cell populations, hyperplastic nodules to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res 1976; 36: 3879–3887
- Judah D J, Legg R F, Neal G E. Development of resistance to cytotoxicity during aflatoxin carcinogenesis. Nature (London) 1977; 265: 343–345
- Farber E. Hyperplastic liver nodules. Methods Cancer Res 1973; 7: 345–375
- Solt D B, Medline A, Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977; 88: 595–618
- Tsuda H, Lee G, Farber E. The induction of resistant hepatocytes as a new principle for a possible short term in vivo test for carcinogens. Cancer Res 1980; 40: 1157–1164
- Cayama E, Tsuda H, Sarma D SR, et al. Initiation of chemical carcinogenesis requires cell proliferation. Nature (London) 1978; 275: 60–61
- Solt D B, Cayama E, Tsuda H, et al. Promotion of liver cancer development by brief exposure to dietary 2-acetylaminofluorene plus partial hepatectomy or carbon tetrachloride. Cancer Res 1983; 43: 188–191
- Ying T S, Enomoto K, Sarma D SR, et al. Effects of delays in the cell cycle on the induction of preneoplastic and neoplastic lesions in rat liver by 1,2-dimethylhydrazine. Cancer Res 1982; 42: 876–880
- Columbano A, Rajalakshmi S, Sarma D SR. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res 1981; 41: 2079–2083
- Hayes M A, Roberts E, Farber E. Initiation and selection of resistant hepatocyte nodules in rat given the pyrrolizidine alkaloids lasiocarpine and senecionine. Cancer Res 1985; 45: 3726–3734
- Rotstein J, Macdonald P DM, Rabes H M, et al. Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis. Cancer Res 1984; 44: 2913–2917
- Lee G, Tatematsu M, Makowka L. The development of hepatocellular carcinoma from carcinogen-altered hepatocytes in the spleen: identification of a new cell population with relevance to cancer. Proc Am Assoc Cancer Res 1983; 24: 106
- Enomoto K, Farber E. Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis. Cancer Res 1982; 42: 2230–2235
- Tatematsu M, Nagamine Y, Farber E. Redifferentiation as a basis for remodelling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res 1983; 43: 5049–5058
- Cameron R, Sweeney G D, Jones K, et al. A relative deficiency of cytochrome P-450 and aryl hydrocarbon (benzo[a]pyrene) hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res 1976; 36: 3888–3893
- Levin W, Lu A YH, Thomas P E, et al. Identification of epoxide hydrase as the preneoplastic antigen in rat liver hyperplastic nodules. Proc Nad Acad Sci (USA) 1978; 75: 3240–3243
- Sharma R N, Gurtoo H L, Farber E, et al. Effects of hepatocarcinogens and hepatocarcinogenesis on the activity of rat liver microsomal epoxide hydrolase and observations on the electrophoretic behaviour of the enyzme. Cancer Res 1981; 41: 3311–3319
- Eriksson L C, Torndal U-B, Andersson G N. Isolation and characterization of endoplasmic reticulum and Golgi apparatus from hepatocyte nodules in male Wistar rats. Cancer Res 1983; 43: 3335–3347
- Roomi M W, Ho R K, Sarma D SR, et al. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res 1985; 45: 564–571
- Satoh K, Kitahara A, Yin Z, et al. Molecular forms of glutathione-S-transferase and UDP-glucuronyltransferase as hepatic preneoplastic marker enzymes. Ann NY Acad Sci 1983; 417: 213–223
- Pickett C B, Williams J B, Lu A YH, et al. Regulation of glutathione S-transferase and DT-diaphorase mRNA in persistent hepatocyte nodules during chemical hepatocarcinogenesis. Proc Natl Acad Sci (USA) 1984; 81: 5091–5095
- Schor N A, Ogawa K, Lee G, et al. The use of the DT-diaphorase for the detection of foci of early neoplastic transformation in rat liver. Cancer Letts 1978; 5: 167–171
- Williams J B, Lu A YH, Cameron R G, et al. Rat liver DT-diaphorase: construction of a DT-diaphorase cDNA clone and regulation of DT-diaphorase mRNA by 3-methylchoIanthrene and in persistent hepatocyte nodules induced by chemical carcinogens. J Biol Chem 1986; 261: 5524–5528
- Cameron R, Kellen J, Kolin A, et al. 7-Glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res 1978; 38: 823–829
- Satoh K, Kitahara A, Soma Y, et al. Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical carcinogenesis. Proc Natl Acad Sci (USA) 1985; 82: 3964–3968
- Rushmore T H, Sharma R NS, Roomi M W, et al. Identification of a characteristic cytosolic polypeptide of rat preneoplastic hepatocyte nodules as placental glutathione S-transferase. Biochem Biophys Res Commun 1987; 143: 98–103
- Moore M A, Nakagawa K, Satoh K, et al. Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis 1987; 8: 483–486
- Cameron R G, Armstrong D, Rushmore T H, et al. Early identification of resistant hepatocytes in response to diethylnitrosamine (DEN) initiation. Toxicologist 1987; 7: 397
- Tatematsu M, Mera Y, Ito N, et al. Relative merits of immunohistochemical demonstration of placental A,B, and C forms of glutathione S-transferase and histochemical demonstration of gamma glutamyl transpeptidase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985; 6: 1621–1626
- Batist G, de Muys J-M, Cowan R H, et al. Purification and characterization of a novel glutathione-S-transferase (GST) in multi-drug resistant (MDR) human breast cancer cells. Proc Am Assoc Cancer Res 1986; 27: 270
- Hayes M A, Roberts E, Safe S H, et al. Influence of different poly-chlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver. J Natl Cancer Inst 1986; 76: 683–691
- Cameron R G, Eriksson L C, Lee G. A novel in vitro - in vivo approach to carcinogenesis studies designed for use with human cells and tissues. Acta Cytol 1984; 28: 614–621
- Lee G, Eriksson L C, Cameron R. The analysis of neoplastic transformation of initiation of chemical hepatocarcinogenesis using a combined in vitro-in vivo approach. Proc Am Assoc Cancer Res 1985; 26: 291
- Ghoshal A K, Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 1984; 5: 1367–1370
- Cameron R G, Imaida K, Tsuda H, et al. Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res 1982; 42: 2426–2428
- Roomi M W, Rao M S, Reddy J K, et al. Modulation of the phenotypic expression of rat hepatocyte nodules (HN) by a hypolipidemic agent, ciprofibrate (CF). Proc Am Assoc Cancer Res 1987; 28: 568
- Kodate C, Fusushi A, Narita T, et al. Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. Gann 1986; 77: 226–229